Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
58010 Results Found
House letter to CMS urging HOPD flexibility in final OPPS rule
As you know, the Centers for Medicare & Medicaid Services (CMS) published on July 6 its calendar year 2017 outpatient prospective payment system (OPPS) proposed rule for implementing Section 60
HHS Motion for Stay
Defendants hereby request that the Court (1) stay this case pending the outcome of the U.S.
Special Bulletin: CMS Releases Advanced Notice of Proposed Rulemaking on Medicare Part B Prescription Drug Payment Model
On October 25, the Centers for Medicare & Medicaid Services issued an advance notice of proposed rulemaking to solicit public comments on potential options for testing a new model for paying for prescription drugs under Medicare Part B provided in physician offices, hospital outpatient departments, and potentially other settings.
Administration Proposes Changes to Medicare Advantage and Part D
The Centers for Medicare & Medicaid Services October 26, released a proposed rule that would make programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2020.
Sustaining Successful Outcomes with the Obstetric Hemorrhage Patient Safety Bundle
Held December 7, 2015
3:00 pm ET (2:00 pm CT; 1:00 pm MT; noon PT)
If you have any questions, please contact Member Relations at 800-424-4301.
Regulatory Advisory: REMINDER: New CMS Price Transparency Requirements Go Into Effect Jan. 1
On Jan. 1, 2019, new price transparency requirements for hospitals will go into effect.
The Value Initiative Members In Action 2018 Summary
The AHA’s Members in Action series spotlights hospitals and health systems that are implementing new value-based strategies to improve health care affordability. This PDF is a synopsis of 2018; read the full case studies here.
AHA: CMS proposal for drug ad transparency ‘important first step’
The AHA voiced support for a Centers for Medicare & Medicaid Services’ proposal to require drug pricing transparency in direct-to-consumer television advertisements and encouraged the agency to
AHA: FTC approach to reviewing hospital transactions seriously flawed
The Federal Trade Commission’s approach to reviewing hospital mergers “is overbroad, does not properly cred